Understanding that not all bladder cancers are the same, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have created a tool that may help them to uncover why only a fraction of patients responds to new immune-based treatments.
All news from Pharmacology and Therapeutics
The study performed to determine whether there is an association between serum vitamin D levels and the Disease Activity Index in patients with rheumatoid arthritis (RA)
In-home rehabilitation, using a telehealth system and supervised by licensed occupational/physical therapists, is an effective means of improving arm motor status in stroke survivors, according to findings presented by University of California, Irvine neurologist Steven C. Cramer, MD, at the recent 2018 European Stroke Organisation Conference in Gothenburg, Sweden.
A new discovery about how the immune system responds to common sinus infections and asthma could explain why patients develop these issues in the first place and ultimately may lead to improved targeted therapies. Researchers have identified the source of the inflammatory cytokine Interleukin-25 (IL-25), an immune molecule that recruits a subset of inflammatory cells.
Common respiratory disorders like chronic rhinosinusitis and asthma have recently been linked to elevated levels of IL-25, but the cellular source of it in the respiratory system was unknown until now. The study findings are published in the Journal of Allergy and Clinical Immunology
The U.S. Food and Drug Administration today approved Palynziq (pegvaliase-pqpz) for adults with a rare and serious genetic disease known as phenylketonuria (PKU). Patients with PKU are born with an inability to break down phenylalanine (Phe), an amino acid present in protein-containing foods and high-intensity sweeteners used in a variety of foods and beverages. Palynziq is a novel enzyme therapy for adult PKU patients who have uncontrolled blood Phe concentrations on current treatment.
The rising incidence of sepsis, a leading cause of in-hospital death, has prompted the Centers for Medicare and Medicaid Services (CMS) to issue protocols known as care bundles to standardize and improve sepsis care. Because of a known association between elevated lactate levels and increased mortality, the guidelines mandate that lactate levels should be tested soon after the onset of sepsis.
Emulate, Inc. has formed a collaborative partnership with AstraZeneca’s Innovative Medicines and Early Development (IMED) Biotech Unit to embed its Organs-on-Chips technology within the laboratories of the IMED Drug Safety organization. As part of the agreement, Emulate plans to co-locate scientists within AstraZeneca’s laboratories.
The aim of this agreement is to accelerate the development of Organs-on-Chips technology and testing within the context of a pharmaceutical organization.
At least 49,000 children in the country are carrying latent tuberculosis and need preventive therapy, according to the International Union against Tuberculosis and Lung Disease.
Among organ transplant patients, those receiving new lungs face a higher rate of organ failure and death compared with people undergoing heart, kidney and liver transplants. One of the culprits is inflammation that damages the newly transplanted lung.
A new environmental monitoring project at Indiana University has found increased numbers of the ticks that carry Lyme disease in Southern Indiana. The organisms, deer ticks, are not yet confirmed to carry Lyme disease. However, IU researchers said the presence of a known disease vector — like a deer tick — is commonly followed by a rise in the illness caused by the bacteria it carries.